Literature DB >> 2710207

Plasma triglyceride levels and coronary disease.

J D Brunzell, M A Austin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2710207     DOI： 10.1056/NEJM198905113201910

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  A prospective study of hyperlipidemia as a pathogenic factor in sudden hearing loss.

Authors:  D Ullrich; G Aurbach; C Drobik
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

2.  Lipoprotein lipase.

Authors:  P W Connelly
Journal:  CMAJ       Date:  1990-08-15       Impact factor: 8.262

3.  Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene.

Authors:  D Ameis; J Kobayashi; R C Davis; O Ben-Zeev; M J Malloy; J P Kane; G Lee; H Wong; R J Havel; M C Schotz
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Doxazosin in the management of hypertensive diabetes--a cautionary note (?).

Authors:  B McLaughlin; L Daly; J G Devlin
Journal:  Ir J Med Sci       Date:  1992-01       Impact factor: 1.568

5.  Plasma lipid concentrations in professional cyclists after competitive cycle races.

Authors:  P Mena; M Maynar; J E Campillo
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

6.  Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.

Authors:  Y Lacourcière; J Lefebvre; P Provencher; L Poirier
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

Review 7.  Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state.

Authors:  H M Roche; M J Gibney
Journal:  Lipids       Date:  1999       Impact factor: 1.646

Review 8.  The pathophysiology of intestinal lipoprotein production.

Authors:  Antonina Giammanco; Angelo B Cefalù; Davide Noto; Maurizio R Averna
Journal:  Front Physiol       Date:  2015-03-20       Impact factor: 4.566
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.